- Home
- / JCR Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
JCR Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥655
2024-10-29
Market Capitalization
¥81.9 B
2024-10-29
Revenue
¥33.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.6B | 23.2B | 24.8B | 30.1B | 51.1B | 34.3B | 42.9B | 33.1B |
| Cost of goods sold | 4.7B | 5.2B | 6.5B | 5.9B | 8.5B | 6.9B | 8.4B | 8.0B |
| Gross profit | 15.8B | 17.9B | 18.3B | 24.2B | 42.6B | 27.5B | 34.4B | 25.1B |
| Gross profit margin, % | 77.0% | 77.4% | 73.9% | 80.3% | 83.3% | 79.9% | 80.4% | 75.9% |
| Operating expense total | 10.7B | 11.6B | 13.6B | 14.0B | 20.7B | 20.5B | 23.7B | 28.4B |
| Depreciation and amortization | 1.4B | 1.3B | 1.4B | 1.9B | 1.9B | 2.0B | 3.2B | 3.4B |
| EBITDA | 5.2B | 6.3B | 4.7B | 10.2B | 21.9B | 7.0B | 9.6B | (3.7B) |
| EBITDA margin, % | 25.1% | 27.2% | 18.9% | 33.8% | 42.8% | 20.3% | 22.5% | -11.3% |
| EBIT | 3.8B | 4.8B | 3.4B | 8.4B | 18.8B | 5.1B | 6.4B | (5.9B) |
| EBIT margin, % | 18.6% | 20.8% | 13.6% | 27.9% | 36.8% | 14.7% | 15.0% | -18.0% |
| Interest income | 20.0M | 20.0M | 19.0M | 7.0M | 7.0M | 33.0M | 111.0M | 113.0M |
| Interest expense | 27.0M | 21.0M | 22.0M | 42.0M | 45.0M | 44.0M | 87.0M | 155.0M |
| Pre tax profit | 3.9B | 4.9B | 3.4B | 8.7B | 19.4B | 5.4B | 7.2B | (6.4B) |
| Income tax expense | 826.0M | 1.2B | 743.0M | 1.8B | 4.9B | 1.6B | 1.7B | (1.7B) |
| Net Income | 3.1B | 3.7B | 2.7B | 6.9B | 14.5B | 3.8B | 5.5B | (4.7B) |